CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 53 filers reported holding CYTEIR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,840 | -81.7% | 1,000 | -83.3% | 0.00% | – |
| Q2 2023 | $15,527 | -93.2% | 5,972 | -95.2% | 0.00% | – |
| Q1 2023 | $227,869 | +356.2% | 125,203 | +313.6% | 0.00% | – |
| Q4 2022 | $49,949 | -62.4% | 30,272 | -56.3% | 0.00% | – |
| Q3 2022 | $133,000 | -79.4% | 69,334 | -67.8% | 0.00% | – |
| Q2 2022 | $645,000 | +7.5% | 215,373 | +35.2% | 0.00% | – |
| Q1 2022 | $600,000 | -39.5% | 159,350 | +82.8% | 0.00% | – |
| Q4 2021 | $992,000 | +1671.4% | 87,191 | +2634.1% | 0.00% | – |
| Q3 2021 | $56,000 | +5500.0% | 3,189 | +4455.7% | 0.00% | – |
| Q2 2021 | $1,000 | – | 70 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,459,572 | $6,985,184 | 15.71% |
| BML Capital Management, LLC | 3,250,008 | $9,230,023 | 8.48% |
| Newtyn Management, LLC | 2,500,444 | $7,101,261 | 1.75% |
| VR Advisory Services Ltd | 1,072,968 | $3,047,229 | 1.08% |
| Anson Funds Management LP | 1,324,114 | $3,760,484 | 0.76% |
| Acuitas Investments, LLC | 329,164 | $934,826 | 0.55% |
| Aldebaran Capital, LLC | 143,739 | $408,219 | 0.42% |
| Bulldog Investors, LLP | 200,000 | $568,000 | 0.20% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 416,200 | $1,182,008 | 0.19% |
| Alta Fundamental Advisers LLC | 117,346 | $333,263 | 0.16% |